

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | valine metabolic process (GO:0006573) | 6.59258421 |
| 2 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48924314 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 5.27929014 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.25400051 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.25149784 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.25149784 |
| 7 | lysine catabolic process (GO:0006554) | 5.17907418 |
| 8 | lysine metabolic process (GO:0006553) | 5.17907418 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.14624943 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.14624943 |
| 11 | triglyceride catabolic process (GO:0019433) | 5.11598678 |
| 12 | biotin metabolic process (GO:0006768) | 4.94180420 |
| 13 | branched-chain amino acid catabolic process (GO:0009083) | 4.88720830 |
| 14 | acylglycerol catabolic process (GO:0046464) | 4.88587990 |
| 15 | neutral lipid catabolic process (GO:0046461) | 4.88587990 |
| 16 | branched-chain amino acid metabolic process (GO:0009081) | 4.84761910 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 4.83973432 |
| 18 | fatty acid oxidation (GO:0019395) | 4.82877662 |
| 19 | tricarboxylic acid metabolic process (GO:0072350) | 4.73800736 |
| 20 | lipid oxidation (GO:0034440) | 4.70996290 |
| 21 | fatty acid catabolic process (GO:0009062) | 4.70811363 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.67253289 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66368712 |
| 24 | DNA unwinding involved in DNA replication (GO:0006268) | 4.60229185 |
| 25 | acetyl-CoA metabolic process (GO:0006084) | 4.57485332 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.55565701 |
| 27 | NADH metabolic process (GO:0006734) | 4.43064088 |
| 28 | DNA strand elongation (GO:0022616) | 4.42756624 |
| 29 | L-serine metabolic process (GO:0006563) | 4.41187958 |
| 30 | protein maturation by protein folding (GO:0022417) | 4.40312643 |
| 31 | cysteine metabolic process (GO:0006534) | 4.39165213 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.37027591 |
| 33 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.33952280 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.29076041 |
| 35 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.27670307 |
| 36 | pentose-phosphate shunt (GO:0006098) | 4.27019447 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.26397884 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.24840225 |
| 39 | 2-oxoglutarate metabolic process (GO:0006103) | 4.23663865 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.23572161 |
| 41 | positive regulation of fatty acid oxidation (GO:0046321) | 4.19345912 |
| 42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.17942314 |
| 43 | regulation of fatty acid oxidation (GO:0046320) | 4.13933987 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 4.13744257 |
| 45 | proline biosynthetic process (GO:0006561) | 4.13279273 |
| 46 | monocarboxylic acid catabolic process (GO:0072329) | 4.12375024 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 4.10352091 |
| 48 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.06651928 |
| 49 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.06164718 |
| 50 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.05334847 |
| 51 | carnitine shuttle (GO:0006853) | 4.05224119 |
| 52 | NADPH regeneration (GO:0006740) | 4.04840307 |
| 53 | carnitine metabolic process (GO:0009437) | 4.04538026 |
| 54 | thioester biosynthetic process (GO:0035384) | 3.98780635 |
| 55 | acyl-CoA biosynthetic process (GO:0071616) | 3.98780635 |
| 56 | tricarboxylic acid cycle (GO:0006099) | 3.90701618 |
| 57 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.89739494 |
| 58 | oxaloacetate metabolic process (GO:0006107) | 3.89647452 |
| 59 | ethanol oxidation (GO:0006069) | 3.89539168 |
| 60 | white fat cell differentiation (GO:0050872) | 3.75119817 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.74712786 |
| 62 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.72853024 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 3.72560950 |
| 64 | complement activation, alternative pathway (GO:0006957) | 3.70253366 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.69486225 |
| 66 | succinate metabolic process (GO:0006105) | 3.69377847 |
| 67 | histone arginine methylation (GO:0034969) | 3.68683276 |
| 68 | bile acid biosynthetic process (GO:0006699) | 3.68265178 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.65902370 |
| 70 | * nucleotide salvage (GO:0043173) | 3.64493714 |
| 71 | DNA replication initiation (GO:0006270) | 3.60293489 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.57084476 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.57084476 |
| 74 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57076693 |
| 75 | organic acid catabolic process (GO:0016054) | 3.55671940 |
| 76 | carboxylic acid catabolic process (GO:0046395) | 3.55671940 |
| 77 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.54627989 |
| 78 | coenzyme A metabolic process (GO:0015936) | 3.53277634 |
| 79 | brown fat cell differentiation (GO:0050873) | 3.51629634 |
| 80 | thioester metabolic process (GO:0035383) | 3.50705531 |
| 81 | acyl-CoA metabolic process (GO:0006637) | 3.50705531 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 3.47039881 |
| 83 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.45969962 |
| 84 | coenzyme A biosynthetic process (GO:0015937) | 3.45541010 |
| 85 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.43445250 |
| 86 | triglyceride metabolic process (GO:0006641) | 3.42430098 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 3.41449451 |
| 88 | triglyceride biosynthetic process (GO:0019432) | 3.41441047 |
| 89 | protein retention in ER lumen (GO:0006621) | 3.41180630 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.41013907 |
| 91 | glycine metabolic process (GO:0006544) | 3.40731056 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 3.39576291 |
| 93 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.39387735 |
| 94 | heterochromatin organization (GO:0070828) | 3.38916062 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 3.37986028 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 3.35476928 |
| 97 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.35386802 |
| 98 | carnitine transport (GO:0015879) | 3.35228959 |
| 99 | amino-acid betaine transport (GO:0015838) | 3.35228959 |
| 100 | serine family amino acid metabolic process (GO:0009069) | 3.35048669 |
| 101 | glycerolipid catabolic process (GO:0046503) | 3.34826526 |
| 102 | pantothenate metabolic process (GO:0015939) | 3.33643802 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 3.30165464 |
| 104 | carnitine transmembrane transport (GO:1902603) | 3.30067371 |
| 105 | peptidyl-arginine N-methylation (GO:0035246) | 3.29951599 |
| 106 | peptidyl-arginine methylation (GO:0018216) | 3.29951599 |
| 107 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.29725030 |
| 108 | kynurenine metabolic process (GO:0070189) | 3.29690050 |
| 109 | protein complex localization (GO:0031503) | 3.28726244 |
| 110 | acylglycerol biosynthetic process (GO:0046463) | 3.28280318 |
| 111 | neutral lipid biosynthetic process (GO:0046460) | 3.28280318 |
| 112 | NADP metabolic process (GO:0006739) | 3.28018788 |
| 113 | * pyrimidine nucleoside salvage (GO:0043097) | 3.25440482 |
| 114 | * pyrimidine-containing compound salvage (GO:0008655) | 3.25440482 |
| 115 | urea cycle (GO:0000050) | 3.24566399 |
| 116 | urea metabolic process (GO:0019627) | 3.24566399 |
| 117 | indole-containing compound catabolic process (GO:0042436) | 3.24356116 |
| 118 | indolalkylamine catabolic process (GO:0046218) | 3.24356116 |
| 119 | tryptophan catabolic process (GO:0006569) | 3.24356116 |
| 120 | regulation of cholesterol metabolic process (GO:0090181) | 3.23945203 |
| 121 | mitotic chromosome condensation (GO:0007076) | 3.23408360 |
| 122 | acylglycerol metabolic process (GO:0006639) | 3.23022246 |
| 123 | deoxyribonucleotide catabolic process (GO:0009264) | 3.20653372 |
| 124 | quaternary ammonium group transport (GO:0015697) | 3.20648401 |
| 125 | regulation of triglyceride metabolic process (GO:0090207) | 3.20040627 |
| 126 | proline metabolic process (GO:0006560) | 3.19128432 |
| 127 | gluconeogenesis (GO:0006094) | 3.17750551 |
| 128 | neutral lipid metabolic process (GO:0006638) | 3.17381077 |
| 129 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.17330137 |
| 130 | establishment of integrated proviral latency (GO:0075713) | 3.17216255 |
| 131 | negative regulation of cell size (GO:0045792) | 3.15823605 |
| 132 | monosaccharide biosynthetic process (GO:0046364) | 3.14765971 |
| 133 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.14598039 |
| 134 | tryptophan metabolic process (GO:0006568) | 3.14252053 |
| 135 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.14009784 |
| 136 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.14009784 |
| 137 | homocysteine metabolic process (GO:0050667) | 3.10992755 |
| 138 | melanin biosynthetic process (GO:0042438) | 3.08371605 |
| 139 | formation of translation preinitiation complex (GO:0001731) | 3.07439811 |
| 140 | UV protection (GO:0009650) | 3.06189809 |
| 141 | mitochondrial fusion (GO:0008053) | 3.04612526 |
| 142 | deoxyribose phosphate catabolic process (GO:0046386) | 3.03572594 |
| 143 | GDP-mannose metabolic process (GO:0019673) | 3.01749761 |
| 144 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.01314270 |
| 145 | glucose catabolic process (GO:0006007) | 3.00959977 |
| 146 | cellular protein complex localization (GO:0034629) | 3.00063462 |
| 147 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.99042082 |
| 148 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.97123165 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.96798264 |
| 150 | telomere maintenance via recombination (GO:0000722) | 2.95472592 |
| 151 | barbed-end actin filament capping (GO:0051016) | 2.95218428 |
| 152 | hexose biosynthetic process (GO:0019319) | 2.95189173 |
| 153 | establishment of viral latency (GO:0019043) | 2.84745698 |
| 154 | pentose metabolic process (GO:0019321) | 2.81745668 |
| 155 | regulation of translational fidelity (GO:0006450) | 2.80094330 |
| 156 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.79108799 |
| 157 | viral transcription (GO:0019083) | 2.78677165 |
| 158 | folic acid metabolic process (GO:0046655) | 2.77580167 |
| 159 | melanin metabolic process (GO:0006582) | 2.76037936 |
| 160 | creatine metabolic process (GO:0006600) | 2.75722873 |
| 161 | base-excision repair (GO:0006284) | 2.74413302 |
| 162 | mitotic nuclear envelope reassembly (GO:0007084) | 2.73225831 |
| 163 | nuclear envelope reassembly (GO:0031468) | 2.73225831 |
| 164 | rRNA transcription (GO:0009303) | 2.73154558 |
| 165 | ribosomal small subunit assembly (GO:0000028) | 2.71843014 |
| 166 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.70098785 |
| 167 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.67144072 |
| 168 | COPI coating of Golgi vesicle (GO:0048205) | 2.66745633 |
| 169 | Golgi transport vesicle coating (GO:0048200) | 2.66745633 |
| 170 | cellular hyperosmotic response (GO:0071474) | 2.66251846 |
| 171 | mitotic recombination (GO:0006312) | 2.66228763 |
| 172 | ribosome biogenesis (GO:0042254) | 2.63922191 |
| 173 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63026616 |
| 174 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.59145276 |
| 175 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56603409 |
| 176 | modulation by virus of host process (GO:0019054) | 2.55964285 |
| 177 | * nucleoside salvage (GO:0043174) | 2.55334117 |
| 178 | regulation of early endosome to late endosome transport (GO:2000641) | 2.53989065 |
| 179 | translational elongation (GO:0006414) | 2.53803852 |
| 180 | purine nucleotide salvage (GO:0032261) | 2.53555235 |
| 181 | IMP biosynthetic process (GO:0006188) | 2.52749010 |
| 182 | dosage compensation (GO:0007549) | 2.52442087 |
| 183 | * pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.51952866 |
| 184 | translational termination (GO:0006415) | 2.51450368 |
| 185 | ncRNA 3-end processing (GO:0043628) | 2.50928782 |
| 186 | regulation of superoxide anion generation (GO:0032928) | 2.50836982 |
| 187 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.50283903 |
| 188 | chaperone-mediated protein transport (GO:0072321) | 2.49552416 |
| 189 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.49188690 |
| 190 | * pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.48234195 |
| 191 | telomere maintenance via telomere lengthening (GO:0010833) | 2.48038649 |
| 192 | protein insertion into membrane (GO:0051205) | 2.47920981 |
| 193 | base-excision repair, AP site formation (GO:0006285) | 2.47270595 |
| 194 | protein localization to endosome (GO:0036010) | 2.45238537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.52855406 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.40367197 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.49404257 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09920494 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.97932727 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.77821324 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.27823643 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18446032 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.03079806 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59892222 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57575575 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.50489274 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.39380593 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.16916443 |
| 15 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00998162 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86351966 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84098906 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78085233 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.77649753 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75698168 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72256868 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67973170 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 1.64750809 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56867020 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.56246788 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.55321620 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54860387 |
| 28 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.50390438 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50275452 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48072245 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47839739 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47658989 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45612990 |
| 34 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38880500 |
| 35 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37235082 |
| 36 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36390116 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35330121 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35107326 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34417616 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33105342 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33093235 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32941984 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32686369 |
| 44 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32213241 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31036670 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30703854 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28842566 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28761252 |
| 49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27020547 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25470896 |
| 51 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.25402410 |
| 52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24190908 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24092917 |
| 54 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23969884 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23432906 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23404795 |
| 57 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.22375970 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22014573 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21645119 |
| 60 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21221742 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18570702 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17758122 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17251048 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16804243 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16321510 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16078655 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15973570 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15890335 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15476743 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14720737 |
| 71 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.14579335 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14009545 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13858325 |
| 74 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13250868 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11903507 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10664161 |
| 77 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09690635 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09276520 |
| 79 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.07383761 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07153770 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06479737 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06144674 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05765168 |
| 84 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05324046 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05259345 |
| 86 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04988528 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04581961 |
| 88 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03767109 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03484648 |
| 90 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03364977 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03241149 |
| 92 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03237651 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01633502 |
| 94 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00918390 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99756093 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99205448 |
| 97 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99118331 |
| 98 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98867968 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98501204 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97217971 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96840283 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96550128 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95983395 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94823781 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94099764 |
| 106 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94013434 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.93746613 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93568818 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93252090 |
| 110 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92653310 |
| 111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92641117 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92594663 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92481434 |
| 114 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92386218 |
| 115 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92328472 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90135703 |
| 117 | * P68_20966046_ChIP-Seq_HELA_Human | 0.89080653 |
| 118 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88471516 |
| 119 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.88383156 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88086234 |
| 121 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87727850 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87581412 |
| 123 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87306192 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85357844 |
| 125 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84880317 |
| 126 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.84714407 |
| 127 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84416891 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 0.84242395 |
| 129 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84014124 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83848687 |
| 131 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.83712977 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 0.82819021 |
| 133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81605355 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81340938 |
| 135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80872420 |
| 136 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80267591 |
| 137 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78879791 |
| 138 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.78679143 |
| 139 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.78608787 |
| 140 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78265222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.58646629 |
| 2 | MP0005360_urolithiasis | 5.22409263 |
| 3 | MP0005670_abnormal_white_adipose | 4.61407467 |
| 4 | MP0005365_abnormal_bile_salt | 4.61098217 |
| 5 | MP0008260_abnormal_autophagy | 3.96718968 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.58082645 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.48605859 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.33324859 |
| 9 | MP0005666_abnormal_adipose_tissue | 3.28233579 |
| 10 | MP0004130_abnormal_muscle_cell | 3.25262550 |
| 11 | MP0003693_abnormal_embryo_hatching | 3.04507052 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.04468217 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.85966075 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.84880420 |
| 15 | MP0005332_abnormal_amino_acid | 2.82188058 |
| 16 | MP0003195_calcinosis | 2.78458191 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.68770747 |
| 18 | MP0004233_abnormal_muscle_weight | 2.57645561 |
| 19 | MP0004858_abnormal_nervous_system | 2.57101222 |
| 20 | MP0009278_abnormal_bone_marrow | 2.56405561 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 2.49135599 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.43547894 |
| 23 | MP0003252_abnormal_bile_duct | 2.41906502 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.39874772 |
| 25 | MP0001849_ear_inflammation | 2.32727032 |
| 26 | MP0000609_abnormal_liver_physiology | 2.30891274 |
| 27 | MP0005375_adipose_tissue_phenotype | 2.27195970 |
| 28 | MP0002971_abnormal_brown_adipose | 2.26919195 |
| 29 | MP0009840_abnormal_foam_cell | 2.25018695 |
| 30 | MP0010030_abnormal_orbit_morphology | 2.16518069 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 2.13794563 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 2.10202025 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 2.07271546 |
| 34 | MP0002822_catalepsy | 2.07095101 |
| 35 | MP0001666_abnormal_nutrient_absorption | 2.06466346 |
| 36 | MP0008932_abnormal_embryonic_tissue | 2.05130187 |
| 37 | MP0003077_abnormal_cell_cycle | 2.03147047 |
| 38 | MP0002249_abnormal_larynx_morphology | 1.95311669 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.91038994 |
| 40 | MP0003186_abnormal_redox_activity | 1.84254400 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.81858351 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.76291854 |
| 43 | MP0001730_embryonic_growth_arrest | 1.73974219 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.71877117 |
| 45 | MP0002970_abnormal_white_adipose | 1.71198666 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.70429482 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.69503508 |
| 48 | MP0005334_abnormal_fat_pad | 1.69064095 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.68873573 |
| 50 | MP0000751_myopathy | 1.68317500 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.65159548 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.63889425 |
| 53 | MP0005535_abnormal_body_temperature | 1.63764132 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.63483076 |
| 55 | MP0008058_abnormal_DNA_repair | 1.63087214 |
| 56 | MP0003123_paternal_imprinting | 1.60873668 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.58463209 |
| 58 | MP0009115_abnormal_fat_cell | 1.57821284 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 1.55557275 |
| 60 | MP0001764_abnormal_homeostasis | 1.55427632 |
| 61 | MP0005083_abnormal_biliary_tract | 1.55104991 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 1.52420858 |
| 63 | MP0003878_abnormal_ear_physiology | 1.52420858 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.48881381 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.44924113 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.43053652 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.42116042 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.39514442 |
| 69 | MP0001756_abnormal_urination | 1.38395515 |
| 70 | MP0000490_abnormal_crypts_of | 1.36085748 |
| 71 | MP0001661_extended_life_span | 1.34684155 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.30657694 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.28875972 |
| 74 | MP0000598_abnormal_liver_morphology | 1.28427579 |
| 75 | MP0000313_abnormal_cell_death | 1.27512610 |
| 76 | MP0003075_altered_response_to | 1.27510703 |
| 77 | MP0003879_abnormal_hair_cell | 1.26811665 |
| 78 | MP0000750_abnormal_muscle_regeneration | 1.24786150 |
| 79 | MP0005501_abnormal_skin_physiology | 1.23639594 |
| 80 | MP0003959_abnormal_lean_body | 1.22902440 |
| 81 | MP0005448_abnormal_energy_balance | 1.22685524 |
| 82 | MP0003136_yellow_coat_color | 1.21041148 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.20054507 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.18580039 |
| 85 | MP0004147_increased_porphyrin_level | 1.15308702 |
| 86 | MP0002080_prenatal_lethality | 1.13417649 |
| 87 | MP0000759_abnormal_skeletal_muscle | 1.13061150 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 1.11833826 |
| 89 | MP0004043_abnormal_pH_regulation | 1.06994874 |
| 90 | MP0005452_abnormal_adipose_tissue | 1.00998570 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 0.99883474 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.99536618 |
| 93 | MP0002269_muscular_atrophy | 0.99407172 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 0.98461579 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.98037355 |
| 96 | MP0009763_increased_sensitivity_to | 0.95540900 |
| 97 | MP0005621_abnormal_cell_physiology | 0.95290264 |
| 98 | MP0003724_increased_susceptibility_to | 0.94620808 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94284944 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.92397989 |
| 101 | MP0002075_abnormal_coat/hair_pigmentati | 0.91864186 |
| 102 | MP0008469_abnormal_protein_level | 0.91819621 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.88986113 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.88986113 |
| 105 | MP0003634_abnormal_glial_cell | 0.88482949 |
| 106 | MP0003011_delayed_dark_adaptation | 0.88447690 |
| 107 | MP0003953_abnormal_hormone_level | 0.88401730 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.87167587 |
| 109 | MP0003868_abnormal_feces_composition | 0.85690367 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.85363009 |
| 111 | MP0002796_impaired_skin_barrier | 0.85226409 |
| 112 | MP0000604_amyloidosis | 0.85197129 |
| 113 | MP0005384_cellular_phenotype | 0.85184935 |
| 114 | MP0009053_abnormal_anal_canal | 0.84940179 |
| 115 | MP0004087_abnormal_muscle_fiber | 0.82598241 |
| 116 | MP0005451_abnormal_body_composition | 0.81332924 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.80908854 |
| 118 | MP0000858_altered_metastatic_potential | 0.80525799 |
| 119 | MP0005220_abnormal_exocrine_pancreas | 0.80473229 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.80245308 |
| 121 | MP0005380_embryogenesis_phenotype | 0.80245308 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.80085792 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.78381869 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.78234400 |
| 125 | MP0001186_pigmentation_phenotype | 0.77782027 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.76903535 |
| 127 | MP0002396_abnormal_hematopoietic_system | 0.76750050 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.76332074 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.75748131 |
| 130 | MP0002019_abnormal_tumor_incidence | 0.72924977 |
| 131 | MP0004510_myositis | 0.71600727 |
| 132 | MP0000749_muscle_degeneration | 0.71319475 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.70945159 |
| 134 | MP0001188_hyperpigmentation | 0.70650057 |
| 135 | MP0005376_homeostasis/metabolism_phenot | 0.69605653 |
| 136 | MP0008872_abnormal_physiological_respon | 0.69569671 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.69257271 |
| 138 | MP0006054_spinal_hemorrhage | 0.68627962 |
| 139 | MP0003786_premature_aging | 0.67292269 |
| 140 | MP0001853_heart_inflammation | 0.66885897 |
| 141 | MP0003329_amyloid_beta_deposits | 0.66298115 |
| 142 | MP0005266_abnormal_metabolism | 0.65714010 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.63933285 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.63919086 |
| 145 | MP0001697_abnormal_embryo_size | 0.62230512 |
| 146 | MP0009672_abnormal_birth_weight | 0.61789944 |
| 147 | MP0010234_abnormal_vibrissa_follicle | 0.61664014 |
| 148 | MP0003984_embryonic_growth_retardation | 0.60949843 |
| 149 | MP0000733_abnormal_muscle_development | 0.60129906 |
| 150 | MP0005275_abnormal_skin_tensile | 0.58865974 |
| 151 | MP0010630_abnormal_cardiac_muscle | 0.58768434 |
| 152 | MP0005423_abnormal_somatic_nervous | 0.58677959 |
| 153 | MP0003303_peritoneal_inflammation | 0.58632142 |
| 154 | MP0008569_lethality_at_weaning | 0.58333677 |
| 155 | MP0002085_abnormal_embryonic_tissue | 0.57744908 |
| 156 | MP0002254_reproductive_system_inflammat | 0.57275807 |
| 157 | MP0000685_abnormal_immune_system | 0.56894258 |
| 158 | MP0000358_abnormal_cell_content/ | 0.56636416 |
| 159 | MP0008874_decreased_physiological_sensi | 0.56038700 |
| 160 | MP0000371_diluted_coat_color | 0.55912582 |
| 161 | MP0000343_altered_response_to | 0.55113695 |
| 162 | MP0005330_cardiomyopathy | 0.54972164 |
| 163 | MP0001881_abnormal_mammary_gland | 0.53442652 |
| 164 | MP0005084_abnormal_gallbladder_morpholo | 0.49254704 |
| 165 | MP0008873_increased_physiological_sensi | 0.48994471 |
| 166 | MP0005464_abnormal_platelet_physiology | 0.48816552 |
| 167 | MP0003690_abnormal_glial_cell | 0.46854965 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.46584743 |
| 169 | MP0000747_muscle_weakness | 0.45652998 |
| 170 | MP0003763_abnormal_thymus_physiology | 0.45533739 |
| 171 | MP0002135_abnormal_kidney_morphology | 0.44687218 |
| 172 | MP0009333_abnormal_splenocyte_physiolog | 0.41081398 |
| 173 | MP0008775_abnormal_heart_ventricle | 0.40919991 |
| 174 | MP0009764_decreased_sensitivity_to | 0.40530173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.44657973 |
| 2 | Hypoglycemic coma (HP:0001325) | 5.23738576 |
| 3 | Abnormality of fatty-acid metabolism (HP:0004359) | 5.02532028 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.96708082 |
| 5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.82572547 |
| 6 | Abnormality of glycine metabolism (HP:0010895) | 4.82572547 |
| 7 | Ketosis (HP:0001946) | 4.70426110 |
| 8 | Hyperammonemia (HP:0001987) | 4.58600240 |
| 9 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.45291925 |
| 10 | Ketoacidosis (HP:0001993) | 4.41057537 |
| 11 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.20601415 |
| 12 | Dicarboxylic aciduria (HP:0003215) | 4.20601415 |
| 13 | Xanthomatosis (HP:0000991) | 4.12431970 |
| 14 | Progressive muscle weakness (HP:0003323) | 4.04236548 |
| 15 | Generalized aminoaciduria (HP:0002909) | 3.96377056 |
| 16 | Hyperglycinemia (HP:0002154) | 3.92236832 |
| 17 | Microvesicular hepatic steatosis (HP:0001414) | 3.73486636 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.63165036 |
| 19 | Increased muscle lipid content (HP:0009058) | 3.62591877 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.55992882 |
| 21 | Vertebral compression fractures (HP:0002953) | 3.52460237 |
| 22 | Hepatic necrosis (HP:0002605) | 3.50218950 |
| 23 | Myoglobinuria (HP:0002913) | 3.44175806 |
| 24 | Myopathic facies (HP:0002058) | 3.41160302 |
| 25 | Complement deficiency (HP:0004431) | 3.39796432 |
| 26 | Broad distal phalanx of finger (HP:0009836) | 3.37530959 |
| 27 | Intrahepatic cholestasis (HP:0001406) | 3.37041412 |
| 28 | Oligomenorrhea (HP:0000876) | 3.36951066 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.35247894 |
| 30 | Hypertriglyceridemia (HP:0002155) | 3.23224828 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.17389254 |
| 32 | Nausea (HP:0002018) | 3.16981888 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 3.03483723 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.02556374 |
| 35 | Hyperacusis (HP:0010780) | 3.00654097 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.96998597 |
| 37 | Lethargy (HP:0001254) | 2.91685164 |
| 38 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.91356608 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.88507372 |
| 40 | Epidermoid cyst (HP:0200040) | 2.86370157 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.85775549 |
| 42 | Stridor (HP:0010307) | 2.83320774 |
| 43 | Achilles tendon contracture (HP:0001771) | 2.82915221 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.80239643 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.75381127 |
| 46 | Abnormality of proline metabolism (HP:0010907) | 2.75381127 |
| 47 | Metabolic acidosis (HP:0001942) | 2.75079526 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74822069 |
| 49 | Hypolipoproteinemia (HP:0010981) | 2.74773850 |
| 50 | Brushfield spots (HP:0001088) | 2.71447307 |
| 51 | Late onset (HP:0003584) | 2.68546070 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.66746560 |
| 53 | Testicular atrophy (HP:0000029) | 2.65487355 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.64534485 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.64301645 |
| 56 | Cerebral edema (HP:0002181) | 2.58762084 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.57268779 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.55663344 |
| 59 | Progressive external ophthalmoplegia (HP:0000590) | 2.55341685 |
| 60 | Dysphonia (HP:0001618) | 2.54556119 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53132338 |
| 62 | Vomiting (HP:0002013) | 2.52305713 |
| 63 | Spastic diplegia (HP:0001264) | 2.51923257 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51837200 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.48435124 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.47882468 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.47777950 |
| 68 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.47637212 |
| 69 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.47637212 |
| 70 | Pancreatitis (HP:0001733) | 2.46840172 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45370761 |
| 72 | Abnormality of complement system (HP:0005339) | 2.43274334 |
| 73 | Insulin resistance (HP:0000855) | 2.42756863 |
| 74 | Distal lower limb muscle weakness (HP:0009053) | 2.42525196 |
| 75 | Limb hypertonia (HP:0002509) | 2.40022941 |
| 76 | Abnormal cartilage morphology (HP:0002763) | 2.39209941 |
| 77 | Patent foramen ovale (HP:0001655) | 2.39004920 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38435479 |
| 79 | Myocardial infarction (HP:0001658) | 2.33384669 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32547302 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32547302 |
| 82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32547302 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 2.30392471 |
| 84 | Abnormality of the umbilical cord (HP:0010881) | 2.30136001 |
| 85 | Gout (HP:0001997) | 2.29294804 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.28746910 |
| 87 | Hypercholesterolemia (HP:0003124) | 2.28653737 |
| 88 | Acanthosis nigricans (HP:0000956) | 2.28565186 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.25263940 |
| 90 | Lactic acidosis (HP:0003128) | 2.25237075 |
| 91 | Truncus arteriosus (HP:0001660) | 2.22997255 |
| 92 | Methylmalonic aciduria (HP:0012120) | 2.18502358 |
| 93 | Calcaneovalgus deformity (HP:0001848) | 2.17371113 |
| 94 | Increased serum pyruvate (HP:0003542) | 2.16569042 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.16569042 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.16475884 |
| 97 | Increased intramyocellular lipid droplets (HP:0012240) | 2.16393958 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 2.16046150 |
| 99 | Upper limb amyotrophy (HP:0009129) | 2.15438893 |
| 100 | Distal upper limb amyotrophy (HP:0007149) | 2.15438893 |
| 101 | Acute encephalopathy (HP:0006846) | 2.14577774 |
| 102 | Annular pancreas (HP:0001734) | 2.14231351 |
| 103 | Trismus (HP:0000211) | 2.13697251 |
| 104 | Degeneration of anterior horn cells (HP:0002398) | 2.07767721 |
| 105 | Abnormality of the anterior horn cell (HP:0006802) | 2.07767721 |
| 106 | Insomnia (HP:0100785) | 2.07517676 |
| 107 | Symptomatic seizures (HP:0011145) | 2.07089911 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07043313 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.05803354 |
| 110 | Glycosuria (HP:0003076) | 2.05803354 |
| 111 | Microretrognathia (HP:0000308) | 2.03241539 |
| 112 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.02803849 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 2.02461518 |
| 114 | Epiphyseal stippling (HP:0010655) | 2.01830418 |
| 115 | Growth hormone excess (HP:0000845) | 2.01155795 |
| 116 | Irritability (HP:0000737) | 2.01109569 |
| 117 | Generalized amyotrophy (HP:0003700) | 2.00829012 |
| 118 | Ankle clonus (HP:0011448) | 1.99746551 |
| 119 | Renal cortical cysts (HP:0000803) | 1.99705984 |
| 120 | Fasciculations (HP:0002380) | 1.98665165 |
| 121 | Back pain (HP:0003418) | 1.98547873 |
| 122 | Skin nodule (HP:0200036) | 1.97820864 |
| 123 | Cholelithiasis (HP:0001081) | 1.95100865 |
| 124 | Neonatal onset (HP:0003623) | 1.94967212 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.92779130 |
| 126 | Cholecystitis (HP:0001082) | 1.92400966 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 1.92400966 |
| 128 | Thin bony cortex (HP:0002753) | 1.92220924 |
| 129 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92218120 |
| 130 | Increased purine levels (HP:0004368) | 1.90645631 |
| 131 | Hyperuricemia (HP:0002149) | 1.90645631 |
| 132 | CNS demyelination (HP:0007305) | 1.89252457 |
| 133 | Conjunctival hamartoma (HP:0100780) | 1.88491887 |
| 134 | Hyperthyroidism (HP:0000836) | 1.88078966 |
| 135 | Ulnar bowing (HP:0003031) | 1.87704308 |
| 136 | Opisthotonus (HP:0002179) | 1.87274461 |
| 137 | Cerebral hypomyelination (HP:0006808) | 1.86711370 |
| 138 | Overriding aorta (HP:0002623) | 1.86639168 |
| 139 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86404927 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86240378 |
| 141 | Hand muscle atrophy (HP:0009130) | 1.85023808 |
| 142 | Hepatocellular carcinoma (HP:0001402) | 1.84395652 |
| 143 | Systemic lupus erythematosus (HP:0002725) | 1.83365739 |
| 144 | Biconcave vertebral bodies (HP:0004586) | 1.82041705 |
| 145 | Fat malabsorption (HP:0002630) | 1.81998051 |
| 146 | Abnormality of methionine metabolism (HP:0010901) | 1.80849523 |
| 147 | Short nail (HP:0001799) | 1.79341984 |
| 148 | Bulbar palsy (HP:0001283) | 1.76965875 |
| 149 | Neoplasm of the adrenal gland (HP:0100631) | 1.76560131 |
| 150 | Increased serum ferritin (HP:0003281) | 1.75874039 |
| 151 | Tachypnea (HP:0002789) | 1.75800085 |
| 152 | Spinal cord lesions (HP:0100561) | 1.75483168 |
| 153 | Syringomyelia (HP:0003396) | 1.75483168 |
| 154 | Difficulty climbing stairs (HP:0003551) | 1.75259535 |
| 155 | Visual hallucinations (HP:0002367) | 1.74635371 |
| 156 | Joint hemorrhage (HP:0005261) | 1.74189926 |
| 157 | Mitral regurgitation (HP:0001653) | 1.74158272 |
| 158 | Nemaline bodies (HP:0003798) | 1.74138012 |
| 159 | Loss of speech (HP:0002371) | 1.72777557 |
| 160 | Increased connective tissue (HP:0009025) | 1.71895710 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.71013618 |
| 162 | Hypertensive crisis (HP:0100735) | 1.70767604 |
| 163 | Tetraplegia (HP:0002445) | 1.70572626 |
| 164 | Selective tooth agenesis (HP:0001592) | 1.69795874 |
| 165 | Pointed chin (HP:0000307) | 1.69250748 |
| 166 | Obstructive sleep apnea (HP:0002870) | 1.68921807 |
| 167 | Partial duplication of thumb phalanx (HP:0009944) | 1.68499705 |
| 168 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.68438215 |
| 169 | Single umbilical artery (HP:0001195) | 1.68438215 |
| 170 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.68438215 |
| 171 | Deformed tarsal bones (HP:0008119) | 1.66535236 |
| 172 | Microglossia (HP:0000171) | 1.66521095 |
| 173 | Supranuclear gaze palsy (HP:0000605) | 1.66417686 |
| 174 | Purpura (HP:0000979) | 1.65832760 |
| 175 | Abnormality of the calcaneus (HP:0008364) | 1.65785846 |
| 176 | Muscle fiber inclusion bodies (HP:0100299) | 1.65075162 |
| 177 | Myokymia (HP:0002411) | 1.64949746 |
| 178 | Reticulocytopenia (HP:0001896) | 1.64363079 |
| 179 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.63687661 |
| 180 | Upper motor neuron abnormality (HP:0002127) | 1.63658513 |
| 181 | Rough bone trabeculation (HP:0100670) | 1.62297655 |
| 182 | External ophthalmoplegia (HP:0000544) | 1.61069502 |
| 183 | Abnormality of the gallbladder (HP:0005264) | 1.60906408 |
| 184 | Depression (HP:0000716) | 1.60781868 |
| 185 | Muscle stiffness (HP:0003552) | 1.60755249 |
| 186 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.58197830 |
| 187 | Transposition of the great arteries (HP:0001669) | 1.58197830 |
| 188 | Abnormal connection of the cardiac segments (HP:0011545) | 1.58197830 |
| 189 | Abnormal gallbladder morphology (HP:0012437) | 1.58180451 |
| 190 | Exercise intolerance (HP:0003546) | 1.58127021 |
| 191 | Polygenic inheritance (HP:0010982) | 1.56419037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.68553562 |
| 2 | TRIB3 | 5.01941537 |
| 3 | SMG1 | 3.93485706 |
| 4 | PKN2 | 3.66370948 |
| 5 | ERN1 | 3.38788680 |
| 6 | SIK1 | 3.30945465 |
| 7 | PRPF4B | 2.91279991 |
| 8 | CAMK1D | 2.87332182 |
| 9 | FLT3 | 2.66158753 |
| 10 | SCYL2 | 2.29382469 |
| 11 | FGFR4 | 2.12893623 |
| 12 | IRAK3 | 2.12869807 |
| 13 | CDC7 | 2.12746927 |
| 14 | VRK2 | 2.09617648 |
| 15 | PRKD3 | 1.94597633 |
| 16 | MAP4K1 | 1.86203509 |
| 17 | NME2 | 1.82441006 |
| 18 | PDK3 | 1.75670842 |
| 19 | PDK4 | 1.75670842 |
| 20 | ARAF | 1.75114920 |
| 21 | MAP3K10 | 1.69014526 |
| 22 | NEK1 | 1.65944763 |
| 23 | LRRK2 | 1.64574419 |
| 24 | TNK2 | 1.62932752 |
| 25 | ICK | 1.57443425 |
| 26 | EEF2K | 1.56762948 |
| 27 | STK16 | 1.54369863 |
| 28 | PBK | 1.45210007 |
| 29 | CAMK1G | 1.45005873 |
| 30 | KDR | 1.38405087 |
| 31 | PTK6 | 1.38124768 |
| 32 | DAPK1 | 1.34612380 |
| 33 | MAP3K11 | 1.31645091 |
| 34 | MAP2K3 | 1.29358334 |
| 35 | ZAP70 | 1.28402196 |
| 36 | LIMK1 | 1.26589341 |
| 37 | PAK6 | 1.25568948 |
| 38 | TGFBR2 | 1.23988253 |
| 39 | TTN | 1.23834617 |
| 40 | AURKA | 1.21109047 |
| 41 | MAPK11 | 1.21015113 |
| 42 | LMTK2 | 1.19985930 |
| 43 | TYK2 | 1.13325990 |
| 44 | BRAF | 1.13194859 |
| 45 | CDK7 | 1.10499830 |
| 46 | GRK6 | 1.04783439 |
| 47 | CDK19 | 1.03611097 |
| 48 | CDK11A | 0.96246029 |
| 49 | JAK3 | 0.93636436 |
| 50 | TESK2 | 0.93094256 |
| 51 | CDK4 | 0.92484894 |
| 52 | CDK15 | 0.91387210 |
| 53 | LATS2 | 0.89120308 |
| 54 | TTK | 0.88915091 |
| 55 | TBK1 | 0.87797982 |
| 56 | JAK2 | 0.86716637 |
| 57 | TAF1 | 0.85904907 |
| 58 | PRKD2 | 0.85851936 |
| 59 | CDK14 | 0.85256183 |
| 60 | CDK18 | 0.83636788 |
| 61 | ATR | 0.83502350 |
| 62 | WEE1 | 0.82811550 |
| 63 | CDK6 | 0.80314040 |
| 64 | BTK | 0.78643907 |
| 65 | CDK8 | 0.78303499 |
| 66 | DAPK2 | 0.77713562 |
| 67 | CAMKK2 | 0.76332188 |
| 68 | TGFBR1 | 0.73927675 |
| 69 | WNK3 | 0.72966707 |
| 70 | NEK2 | 0.71851073 |
| 71 | CAMK2G | 0.70133147 |
| 72 | CSF1R | 0.69437767 |
| 73 | AURKB | 0.67309223 |
| 74 | PDGFRA | 0.67260835 |
| 75 | ITK | 0.67004861 |
| 76 | TESK1 | 0.66581660 |
| 77 | MAPKAPK3 | 0.66364188 |
| 78 | CDK9 | 0.65924295 |
| 79 | MAPK12 | 0.63814611 |
| 80 | ALK | 0.63374734 |
| 81 | WNK4 | 0.61897652 |
| 82 | PRKAA2 | 0.61298274 |
| 83 | DMPK | 0.60199950 |
| 84 | RIPK1 | 0.59967553 |
| 85 | CHEK2 | 0.59900645 |
| 86 | JAK1 | 0.59190244 |
| 87 | PASK | 0.58470371 |
| 88 | PLK1 | 0.58253075 |
| 89 | ABL2 | 0.58078430 |
| 90 | MAP3K1 | 0.57940619 |
| 91 | MAP2K1 | 0.57873059 |
| 92 | BMX | 0.57850431 |
| 93 | PAK1 | 0.57641478 |
| 94 | IRAK2 | 0.57631608 |
| 95 | MAPK4 | 0.57559458 |
| 96 | MOS | 0.56242239 |
| 97 | ACVR1B | 0.55215991 |
| 98 | FGFR2 | 0.52684469 |
| 99 | DYRK1B | 0.52130814 |
| 100 | EIF2AK3 | 0.52075479 |
| 101 | NEK9 | 0.51462045 |
| 102 | CDK12 | 0.50590352 |
| 103 | PDK1 | 0.48440006 |
| 104 | PDPK1 | 0.47774062 |
| 105 | MST1R | 0.47762385 |
| 106 | CHEK1 | 0.47429580 |
| 107 | BRSK1 | 0.46861129 |
| 108 | BRSK2 | 0.46654641 |
| 109 | MAP3K8 | 0.46458744 |
| 110 | PRKAA1 | 0.44420611 |
| 111 | TAOK2 | 0.43766172 |
| 112 | MTOR | 0.43538780 |
| 113 | EIF2AK1 | 0.43197576 |
| 114 | TAOK1 | 0.42818226 |
| 115 | RET | 0.42809618 |
| 116 | KIT | 0.42155099 |
| 117 | ILK | 0.42137747 |
| 118 | PRKACG | 0.42112736 |
| 119 | BUB1 | 0.41965080 |
| 120 | CAMK2B | 0.40367712 |
| 121 | PAK2 | 0.39489804 |
| 122 | MAP3K7 | 0.39089637 |
| 123 | SYK | 0.38999292 |
| 124 | RPS6KL1 | 0.37814383 |
| 125 | RPS6KC1 | 0.37814383 |
| 126 | SRPK1 | 0.37283617 |
| 127 | MAP3K3 | 0.37090546 |
| 128 | CDK2 | 0.36355325 |
| 129 | GSK3A | 0.35209308 |
| 130 | RAF1 | 0.34510073 |
| 131 | STK10 | 0.33601878 |
| 132 | AKT2 | 0.33147464 |
| 133 | PIK3CG | 0.32986615 |
| 134 | PAK4 | 0.32836597 |
| 135 | RPS6KA4 | 0.32497549 |
| 136 | KSR2 | 0.32480026 |
| 137 | UHMK1 | 0.32349537 |
| 138 | CAMKK1 | 0.31909154 |
| 139 | PINK1 | 0.31066386 |
| 140 | MARK2 | 0.30692819 |
| 141 | INSRR | 0.30656110 |
| 142 | CAMK2D | 0.30462806 |
| 143 | CAMK1 | 0.29943660 |
| 144 | PIM2 | 0.29913083 |
| 145 | RPS6KB2 | 0.29772165 |
| 146 | MAP2K2 | 0.29546735 |
| 147 | PRKG2 | 0.28119002 |
| 148 | PRKCH | 0.26985642 |
| 149 | HIPK2 | 0.26114243 |
| 150 | DAPK3 | 0.24823241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.81643934 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.61428575 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.51769569 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.42855812 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.09157451 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.05523889 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.03837642 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.79006776 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.76854482 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.45778958 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45548876 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26835960 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.25417624 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23358085 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22427321 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21512562 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.16486844 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.97944563 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95105613 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.82574622 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73631255 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71240335 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68517372 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.68066573 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.68063091 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58243710 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56218602 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52600006 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.51106364 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48053045 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41916838 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41701550 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32193911 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28559533 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27689635 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26679304 |
| 37 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26277045 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25222632 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23366594 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.22778827 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19701588 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18113202 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17821333 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16043730 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14472515 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13580442 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11613809 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10829129 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08951720 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 1.07413272 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05905869 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04084759 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03940626 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03522571 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.00712025 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00407149 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00316958 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.98094959 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97115476 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.96817005 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96515039 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95065898 |
| 63 | RNA polymerase_Homo sapiens_hsa03020 | 0.92976215 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92262576 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92141213 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91700339 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91143844 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90938143 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86996367 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86410278 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85960016 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85023980 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.83208451 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83051785 |
| 75 | DNA replication_Homo sapiens_hsa03030 | 0.78877313 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75334342 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75054647 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.73402099 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72677053 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72516103 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.72096196 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69281761 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68831205 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67823757 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66969760 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65845729 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.65354215 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61404467 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60456966 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.60263313 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59900798 |
| 92 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56637929 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53841500 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53725193 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53454412 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53252562 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51606536 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50900669 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49482579 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47155425 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46501594 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45160297 |
| 103 | Ribosome_Homo sapiens_hsa03010 | 0.44593703 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43653425 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42443921 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.42390354 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.41957804 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41817350 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40353970 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.39546851 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39303512 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.38922987 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38184701 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36628368 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36029867 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35937442 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34933767 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33852071 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32532201 |
| 120 | Base excision repair_Homo sapiens_hsa03410 | 0.32134749 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.32005694 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31651876 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31471583 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | 0.30560874 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28561796 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28391064 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27552065 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26971943 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26150186 |
| 130 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.24528101 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23803954 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21895957 |
| 133 | Proteasome_Homo sapiens_hsa03050 | 0.16366291 |
| 134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15503009 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.14270137 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12739645 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.11383964 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.08665006 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04109690 |
| 140 | Huntingtons disease_Homo sapiens_hsa05016 | 0.02337439 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.01592892 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.01513406 |
| 143 | Alzheimers disease_Homo sapiens_hsa05010 | 0.00428124 |
| 144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0523257 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0511113 |
| 146 | Protein export_Homo sapiens_hsa03060 | -0.0034336 |

